Advertisement
UK markets closed
  • FTSE 100

    7,962.27
    +30.29 (+0.38%)
     
  • FTSE 250

    19,908.26
    +97.60 (+0.49%)
     
  • AIM

    744.34
    +2.23 (+0.30%)
     
  • GBP/EUR

    1.1701
    +0.0032 (+0.27%)
     
  • GBP/USD

    1.2641
    +0.0003 (+0.02%)
     
  • Bitcoin GBP

    56,114.02
    +1,409.75 (+2.58%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,250.90
    +2.41 (+0.05%)
     
  • DOW

    39,763.30
    +3.22 (+0.01%)
     
  • CRUDE OIL

    82.66
    +1.31 (+1.61%)
     
  • GOLD FUTURES

    2,238.20
    +25.50 (+1.15%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,494.81
    +17.72 (+0.10%)
     
  • CAC 40

    8,209.61
    +4.80 (+0.06%)
     

Extreme Tech Challenge Global Finals: Startup Pitches Part 2 - PathGen

PathGen Diagnostik Teknologi disrupts the molecular diagnostics market for cancer through inclusive, robust, and affordable platforms. With a strong ecosystem of academic-business-government-community partnership, PathGen seeks to democratize precision medicine, especially in developing countries, and enable molecular diagnostics for all.